Can a simple blood test predict if a pregnant woman will pass HCMV to her baby?
NCT ID NCT07477925
First seen Mar 28, 2026 · Last updated May 24, 2026 · Updated 10 times
Summary
This study aims to find immune markers that can predict whether a pregnant woman with a first-time HCMV infection will pass the virus to her unborn baby. Researchers will analyze blood samples from 90 pregnant women and newborns to see which immune responses are linked to lower transmission risk. No treatment is given; the goal is to improve risk assessment and guide future vaccine development.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN CYTOMEGALOVIRUS (HCMV) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione IRCCS Policlinico San Matteo
RECRUITINGPavia, Lombardy, 27100, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.